HUMORAL IMMUNOGENICITY TO A SECOND AND THIRD DOSE OF COVID-19 VACCINE BNT162B2 IN PATIENTS WITH SPONDYLOARTHRITIS RECEIVING SECUKINUMAB: A PROSPECTIVE STUDY
AGING CLINICAL AND EXPERIMENTAL RESEARCH(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要